Fig. 2From: A multi-parametric prognostic model based on clinical features and serological markers predicts overall survival in non-small cell lung cancer patients with chronic hepatitis B viral infectionComparison of predictive accuracy between prognostic model, TNM staging, and clinical treatment using time dependent ROC curves at 1-, 3-, 5-year (a–c) in training cohort (left) and validation cohort (right)Back to article page